Genes from the RTK/PI3K pathway, including PTEN, PIK3R1 in glioma, and ALK, PIK3C2G, ERBB4 in melanoma, showed lower mutation rates in AYAs, reiterating our earlier observation on recurrent genes. This evidence concerns the gene PTEN and central nervous system cancer.